ReviewCurrent hematologic malignancy reports2019

Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma.

Murali Kesavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.